Key facts
- Notable investors include Nanjing Jiangbei New Area Science and Technology Investment Group, Triwise Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Pet Medtech
- ·The full record, as it builds
Funding rounds
No funding rounds for Pet Medtech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pet Medtech
Manufacturer of veterinary pharmaceuticals intended to advance pet health through innovative drug development and disease prevention. The company offers proprietary research pipelines, cutting-edge veterinary instruments, and a dedicated health technology platform, enabling pet owners and veterinary professionals to access effective treatments and improved animal care.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2023
- Website
- petmedtech.com/
- Ownership
- Privately Held (backing)
Pet Medtech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pet Medtech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pet Medtech in its N-PORT filings yet. We sweep new filings monthly.